Cedars-Sinai Medical Center

Hospital, FunderROROpenAlexWikidata

People

Sources: reporter.nih.gov

Founded

  • Founded

    Jun 30, 1902

Sources: search.gleif.org

Trials

Sources: clinicaltrials.gov

Grants and prizes

  • National Cancer Institute

    R01, Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer, R01CA280060, $692K, 2023–2028, Sep 17, 2026

  • National Institute on Aging

    P30, Los Angeles Claude D. Pepper Older Americans Independence Center, P30AG094848, $1.3M, 2025–2030, Sep 17, 2026

  • National Institute on Aging

    K01, Research Continuity Supplement K01AG090692, K01AG090692, $75.1K, 2025–2030, Sep 11, 2026

  • National Heart, Lung, and Blood Institute

    R01, Dynamic Predictors of Sudden Cardiac Death, R01HL181473, $1.7M, 2026–2028, Sep 9, 2026

  • National Heart, Lung, and Blood Institute

    R01, Role of the Endocannabinoid System, Metabolic Disease Progression, and Associated Cardiovascular Risk, R01HL184098, $854K, 2026–2030, Aug 31, 2026

  • National Institute on Aging

    R01, Federated Transfer Learning Framework to Improve Genetic Risk Prediction for Alzheimer's Disease and Related Dementias, R01AG094962, $809K, 2026–2031, Aug 25, 2026

  • National Institute of Allergy and Infectious Diseases

    R21, Vascular niche restoration to prevent delayed effects of acute radiation exposure (DEARE) in the hematopoietic system, R21AI193964, $167K, 2025–2027, Aug 21, 2026

  • National Institute on Aging

    U54, The Microvascular Aging Effects - Women's Evaluation of Systemic aging Tenacity in Heart, Brain and Frailty (MAE-WEST HBF) ("You are never too old to become younger!"), U54AG094168, $1.5M, 2025–2030, Aug 20, 2026

  • National Institute on Aging

    UG3, Using microgravity to model inflammaging in complex organ chip models of heart, gut, and brain, UG3AG099469, $1.2M, 2025–2028, Aug 18, 2026

  • National Cancer Institute

    K22, Etiology and Tumor Characteristics of Early-onset Pancreatic Cancer, K22CA288914, $192K, 2025–2028, Aug 7, 2026

  • National Cancer Institute

    R01, Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes, R01CA280081, $681K, 2023–2028, Jul 28, 2026

  • National Cancer Institute

    R35, Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance, R35CA283706, $918K, 2024–2031, Jul 22, 2026

  • National Institute on Aging

    R01, p53 acetylation drives alveolar progenitor cells senescence in progressive pulmonary fibrosis, R01AG097434, $671K, 2026–2031, Jul 17, 2026

  • National Institute on Aging

    R01, Targeting Biology of Aging Mechanisms Underlying Alzheimer's Disease Risk with Metformin, R01AG089711, $712K, 2024–2029, Jul 15, 2026

  • National Institute on Aging

    R33, Translational Geroscience Network, R33AG061456, $702K, 2019–2029, Jul 14, 2026

  • National Institute of Diabetes and Digestive and Kidney Diseases

    RC2, Consortium on Intestinal Regeneration and Fetal Reversion: from Atlas to Therapy, RC2DK140862, $2M, 2024–2029, Jul 7, 2026

  • National Cancer Institute

    R21, A phase I trial of S-Adenosylmethionine (SAMe) for chemoprevention of colorectal adenomas, R21CA313077, $340K, 2026–2028, Jun 30, 2026

  • National Institute on Aging

    R01, Alzheimer's Disease Hallmark Pathology and Associated Inflammation in the Retina, R01AG055865, $803K, 2018–2028, Jun 18, 2026

  • National Cancer Institute

    R01, Impact of exogenous hormones on Prostate Cancer Risk, Detection, and Outcomes in the Nationwide Veterans Affairs Health System, R01CA300694, $647K, 2026–2031, Jun 16, 2026

  • National Institute of Diabetes and Digestive and Kidney Diseases

    R01, Inhibition of an Apical cAMP/cGMP Transporter (MRP4) in the Gut Induces Diarrhea, R01DK080834, $576K, 2009–2028, Jun 3, 2026

Sources: reporter.nih.gov

Grants and prizes awarded

  • Regent University

    Hydrogen Sulfide and GLP-1 Combination Therapy to Treat HFpEF (sub-award to THE REGENTS OF THE UNIVERSITY OF COLORADO), usaspending_subaward/ASST_NON_R01HL181016_075/MW8JHK6ZYEX8, $61.6K, 2026, Jul 21, 2026

  • Harvard University

    Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators (sub-award to PRESIDENT AND FELLOWS OF HARVARD COLLEGE), usaspending_subaward/ASST_NON_R01CA258222_075/UNVDZNFA8R29, $50.9K, 2026, Apr 2, 2026

  • The University of Texas at Arlington

    The Microvascular Aging Effects (sub-award to UNIVERSITY OF TEXAS AT ARLINGTON), usaspending_subaward/ASST_NON_U54AG094168_075/LMLUKUPJJ9N3, $37.3K, 2026, Apr 2, 2026

  • California Institute of Technology

    Hypothalamic Pathways of Age Related Homeostatic Dysregulation (sub-award to CALIFORNIA INSTITUTE OF TECHNOLOGY), usaspending_subaward/ASST_NON_RF1AG091203_075/U2JMKHNS5TG4, $66.9K, 2026, Jan 22, 2026

  • Rutgers University

    Consortium on Intestinal Regeneration and Fetal Reversion: from Atlas to Therapy (sub-award to RUTGERS, THE STATE UNIVERSITY), usaspending_subaward/ASST_NON_RC2DK140862_075/M1LVPE5GLSD9, $438K, 2025, Aug 27, 2025

  • University of Michigan

    Consortium on Intestinal Regeneration and Fetal Reversion: from Atlas to Therapy (sub-award to REGENTS OF THE UNIVERSITY OF MICHIGAN), usaspending_subaward/ASST_NON_RC2DK140862_075/GNJ7BBP73WE9, $875K, 2025, Mar 4, 2025

  • Baylor University

    Consortium on Intestinal Regeneration and Fetal Reversion: from Atlas to Therapy (sub-award to BAYLOR COLLEGE OF MEDICINE), usaspending_subaward/ASST_NON_RC2DK140862_075/FXKMA43NTV21, 2025, Feb 13, 2025

  • Baylor College of Medicine

    Consortium on Intestinal Regeneration and Fetal Reversion: from Atlas to Therapy (sub-award to BAYLOR COLLEGE OF MEDICINE), usaspending_subaward/ASST_NON_RC2DK140862_075/FXKMA43NTV21, $881K, 2025, Lead, Feb 13, 2025

Sources: openalex.org

Funded papers

Sources: api.crossref.org, openalex.org

Named in competing interests

Sources: pubmed.ncbi.nlm.nih.gov

Papers